

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.54126959 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.54126959 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.48898336 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.21590538 |
| 5 | GMP metabolic process (GO:0046037) | 5.11224906 |
| 6 | short-term memory (GO:0007614) | 5.07331236 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.03124608 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.03124608 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 5.03124608 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 5.03124608 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 5.03124608 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.03124608 |
| 13 | neuronal action potential propagation (GO:0019227) | 4.90094642 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.78050629 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.70497468 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 4.68111896 |
| 17 | detection of other organism (GO:0098543) | 4.66576622 |
| 18 | negative regulation of interleukin-12 production (GO:0032695) | 4.65650944 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 4.61445200 |
| 20 | immunoglobulin mediated immune response (GO:0016064) | 4.54606458 |
| 21 | response to peptidoglycan (GO:0032494) | 4.54177064 |
| 22 | detection of bacterium (GO:0016045) | 4.50409939 |
| 23 | negative regulation of heart rate (GO:0010459) | 4.46908156 |
| 24 | presynaptic membrane assembly (GO:0097105) | 4.42007788 |
| 25 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 4.36613406 |
| 26 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.32485305 |
| 27 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.17673002 |
| 28 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.17576670 |
| 29 | detection of external biotic stimulus (GO:0098581) | 4.00382417 |
| 30 | regulation of pigment cell differentiation (GO:0050932) | 3.93022187 |
| 31 | postsynaptic membrane organization (GO:0001941) | 3.92902635 |
| 32 | type I interferon signaling pathway (GO:0060337) | 3.92552495 |
| 33 | cellular response to type I interferon (GO:0071357) | 3.92552495 |
| 34 | response to type I interferon (GO:0034340) | 3.91006785 |
| 35 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.88723704 |
| 36 | regulation of gamma-delta T cell activation (GO:0046643) | 3.85348266 |
| 37 | detection of molecule of bacterial origin (GO:0032490) | 3.82427178 |
| 38 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.79397539 |
| 39 | melanin metabolic process (GO:0006582) | 3.77022874 |
| 40 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.75735463 |
| 41 | presynaptic membrane organization (GO:0097090) | 3.73088835 |
| 42 | regulation of mast cell degranulation (GO:0043304) | 3.66024618 |
| 43 | microglial cell activation (GO:0001774) | 3.63396286 |
| 44 | positive regulation of dendritic spine development (GO:0060999) | 3.63206697 |
| 45 | androgen biosynthetic process (GO:0006702) | 3.61428142 |
| 46 | neutrophil activation (GO:0042119) | 3.57819343 |
| 47 | cellular extravasation (GO:0045123) | 3.53258484 |
| 48 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.49563043 |
| 49 | response to host immune response (GO:0052572) | 3.49563043 |
| 50 | respiratory burst (GO:0045730) | 3.49191256 |
| 51 | facial nerve structural organization (GO:0021612) | 3.48428770 |
| 52 | positive regulation of mast cell activation (GO:0033005) | 3.48020486 |
| 53 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.47514683 |
| 54 | detection of biotic stimulus (GO:0009595) | 3.47040306 |
| 55 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.46950370 |
| 56 | granulocyte activation (GO:0036230) | 3.46675486 |
| 57 | leukocyte aggregation (GO:0070486) | 3.45546382 |
| 58 | response to folic acid (GO:0051593) | 3.41718487 |
| 59 | defense response to protozoan (GO:0042832) | 3.40269768 |
| 60 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.40128928 |
| 61 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.38594050 |
| 62 | myeloid cell activation involved in immune response (GO:0002275) | 3.37751318 |
| 63 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.37294239 |
| 64 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.37153055 |
| 65 | regulation of antigen processing and presentation (GO:0002577) | 3.36422588 |
| 66 | macrophage activation (GO:0042116) | 3.36351121 |
| 67 | regulation of mast cell activation (GO:0033003) | 3.36192031 |
| 68 | B cell mediated immunity (GO:0019724) | 3.36084189 |
| 69 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.35169359 |
| 70 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.35164052 |
| 71 | cranial nerve morphogenesis (GO:0021602) | 3.34514193 |
| 72 | positive regulation of antigen processing and presentation (GO:0002579) | 3.34150142 |
| 73 | endothelium development (GO:0003158) | 3.34038915 |
| 74 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.32841615 |
| 75 | neuron cell-cell adhesion (GO:0007158) | 3.32482711 |
| 76 | positive regulation of protein homodimerization activity (GO:0090073) | 3.31284078 |
| 77 | regulation of T cell tolerance induction (GO:0002664) | 3.30064338 |
| 78 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.23713510 |
| 79 | melanin biosynthetic process (GO:0042438) | 3.22142592 |
| 80 | cAMP catabolic process (GO:0006198) | 3.20921032 |
| 81 | regulation of leukocyte degranulation (GO:0043300) | 3.20735671 |
| 82 | negative regulation of T cell mediated immunity (GO:0002710) | 3.20629384 |
| 83 | entrainment of circadian clock by photoperiod (GO:0043153) | 3.19743130 |
| 84 | respiratory electron transport chain (GO:0022904) | 3.19605474 |
| 85 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.18509710 |
| 86 | response to host (GO:0075136) | 3.18509710 |
| 87 | response to host defenses (GO:0052200) | 3.18509710 |
| 88 | regulation of relaxation of muscle (GO:1901077) | 3.17396372 |
| 89 | B cell receptor signaling pathway (GO:0050853) | 3.17370216 |
| 90 | regulation of cell communication by electrical coupling (GO:0010649) | 3.17315248 |
| 91 | positive regulation of synapse assembly (GO:0051965) | 3.15983314 |
| 92 | response to muramyl dipeptide (GO:0032495) | 3.14206921 |
| 93 | electron transport chain (GO:0022900) | 3.13338652 |
| 94 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.12204890 |
| 95 | positive regulation of mast cell degranulation (GO:0043306) | 3.12204890 |
| 96 | response to protozoan (GO:0001562) | 3.11889450 |
| 97 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.11331052 |
| 98 | protein localization to cilium (GO:0061512) | 3.09839314 |
| 99 | regulation of tolerance induction (GO:0002643) | 3.08170972 |
| 100 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.07234938 |
| 101 | cyclic nucleotide catabolic process (GO:0009214) | 3.06367194 |
| 102 | T-helper 1 type immune response (GO:0042088) | 3.01281723 |
| 103 | ATP synthesis coupled proton transport (GO:0015986) | 3.00866886 |
| 104 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.00866886 |
| 105 | tolerance induction (GO:0002507) | 2.99421903 |
| 106 | entrainment of circadian clock (GO:0009649) | 2.98853335 |
| 107 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.98641778 |
| 108 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.97120229 |
| 109 | positive thymic T cell selection (GO:0045059) | 2.96759670 |
| 110 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.96234284 |
| 111 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.96002790 |
| 112 | negative regulation of innate immune response (GO:0045824) | 2.95563257 |
| 113 | positive regulation of interferon-alpha production (GO:0032727) | 2.95390967 |
| 114 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.95344170 |
| 115 | regulation of interferon-alpha production (GO:0032647) | 2.94961474 |
| 116 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.93297877 |
| 117 | positive regulation of type 2 immune response (GO:0002830) | 2.92178783 |
| 118 | positive regulation of membrane potential (GO:0045838) | 2.91492864 |
| 119 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.91371603 |
| 120 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.91268511 |
| 121 | germinal center formation (GO:0002467) | 2.90881994 |
| 122 | NIK/NF-kappaB signaling (GO:0038061) | 2.90565074 |
| 123 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.90500320 |
| 124 | protein localization to synapse (GO:0035418) | 2.89722877 |
| 125 | T cell migration (GO:0072678) | 2.88502595 |
| 126 | protein heterotetramerization (GO:0051290) | 2.87752512 |
| 127 | cellular response to interferon-gamma (GO:0071346) | 2.87070348 |
| 128 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.86962308 |
| 129 | cranial nerve structural organization (GO:0021604) | 2.85454825 |
| 130 | negative regulation of interleukin-6 production (GO:0032715) | 2.85084980 |
| 131 | mannosylation (GO:0097502) | 2.84933548 |
| 132 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.84500327 |
| 133 | sympathetic nervous system development (GO:0048485) | 2.84159391 |
| 134 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.82727798 |
| 135 | enteric nervous system development (GO:0048484) | 2.81586924 |
| 136 | positive regulation of B cell differentiation (GO:0045579) | 2.81094885 |
| 137 | regulation of regulated secretory pathway (GO:1903305) | 2.76986647 |
| 138 | membrane assembly (GO:0071709) | 2.76754941 |
| 139 | neutrophil mediated immunity (GO:0002446) | 2.76061208 |
| 140 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.75460159 |
| 141 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.74876896 |
| 142 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.74153226 |
| 143 | secondary metabolite biosynthetic process (GO:0044550) | 2.71695615 |
| 144 | myeloid dendritic cell differentiation (GO:0043011) | 2.71425339 |
| 145 | regulation of type 2 immune response (GO:0002828) | 2.71389590 |
| 146 | positive regulation of amino acid transport (GO:0051957) | 2.71369479 |
| 147 | respiratory chain complex IV assembly (GO:0008535) | 2.70522176 |
| 148 | regulation of B cell differentiation (GO:0045577) | 2.70111791 |
| 149 | response to interferon-gamma (GO:0034341) | 2.69910819 |
| 150 | myeloid leukocyte activation (GO:0002274) | 2.69123475 |
| 151 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.69014666 |
| 152 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.68342366 |
| 153 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.67550516 |
| 154 | chaperone-mediated protein transport (GO:0072321) | 2.66484422 |
| 155 | photoperiodism (GO:0009648) | 2.65461104 |
| 156 | GTP biosynthetic process (GO:0006183) | 2.64450530 |
| 157 | central nervous system neuron axonogenesis (GO:0021955) | 2.63066045 |
| 158 | axon ensheathment in central nervous system (GO:0032291) | 2.62678208 |
| 159 | central nervous system myelination (GO:0022010) | 2.62678208 |
| 160 | DNA ligation (GO:0006266) | 2.61781998 |
| 161 | righting reflex (GO:0060013) | 2.60366288 |
| 162 | protein neddylation (GO:0045116) | 2.59720003 |
| 163 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.59710960 |
| 164 | aldehyde catabolic process (GO:0046185) | 2.58398813 |
| 165 | regulation of protein kinase A signaling (GO:0010738) | 2.50896201 |
| 166 | regulation of synapse assembly (GO:0051963) | 2.48533778 |
| 167 | regulation of ruffle assembly (GO:1900027) | 2.41081780 |
| 168 | neuronal action potential (GO:0019228) | 2.40438352 |
| 169 | positive regulation of action potential (GO:0045760) | 2.39722607 |
| 170 | vocalization behavior (GO:0071625) | 2.39327607 |
| 171 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.37386742 |
| 172 | cytochrome complex assembly (GO:0017004) | 2.37229649 |
| 173 | positive regulation of steroid hormone secretion (GO:2000833) | 2.35714552 |
| 174 | serotonin receptor signaling pathway (GO:0007210) | 2.35632323 |
| 175 | peripheral nervous system neuron development (GO:0048935) | 2.35425666 |
| 176 | negative regulation of cation channel activity (GO:2001258) | 2.33763903 |
| 177 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.33698337 |
| 178 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.33474128 |
| 179 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.31651536 |
| 180 | protein complex biogenesis (GO:0070271) | 2.29880242 |
| 181 | generation of neurons (GO:0048699) | 2.29549309 |
| 182 | glutamate receptor signaling pathway (GO:0007215) | 2.28564265 |
| 183 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.27630982 |
| 184 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.27627814 |
| 185 | negative regulation of norepinephrine secretion (GO:0010700) | 2.27490014 |
| 186 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.26964785 |
| 187 | lymphoid progenitor cell differentiation (GO:0002320) | 2.26251002 |
| 188 | axon development (GO:0061564) | 2.25001839 |
| 189 | positive regulation of protein kinase C signaling (GO:0090037) | 2.24910876 |
| 190 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.24895651 |
| 191 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.24895651 |
| 192 | oligodendrocyte differentiation (GO:0048709) | 2.24109948 |
| 193 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.24019027 |
| 194 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.24019027 |
| 195 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.23807530 |
| 196 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.23406481 |
| 197 | developmental pigmentation (GO:0048066) | 2.23030016 |
| 198 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.22810759 |
| 199 | response to pain (GO:0048265) | 2.22633832 |
| 200 | omega-hydroxylase P450 pathway (GO:0097267) | 10.0723484 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 7.39335409 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.31656530 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.69223930 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.21271198 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.14567095 |
| 6 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.93229611 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.72063105 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.42349382 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.37543311 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.30995861 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.27343288 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.18717199 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.95759163 |
| 14 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.87566126 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.68194157 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.55276160 |
| 17 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.51770717 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.50089857 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.48848776 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.43921945 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.42712288 |
| 22 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.42001859 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.41280345 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.39261821 |
| 25 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.38606124 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.38366059 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.36641181 |
| 28 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.35976417 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 2.34676236 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.34512372 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.30865166 |
| 32 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.28879335 |
| 33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.27923174 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.27397156 |
| 35 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.24277580 |
| 36 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.24277580 |
| 37 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.20849850 |
| 38 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.17303126 |
| 39 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.15467837 |
| 40 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.15005844 |
| 41 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.14883527 |
| 42 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.13014444 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.12796040 |
| 44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.99883370 |
| 45 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.99635553 |
| 46 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.99231278 |
| 47 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.97026297 |
| 48 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.95212120 |
| 49 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.94694265 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.94645985 |
| 51 | MAF_26560356_Chip-Seq_TH1_Human | 1.94030433 |
| 52 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93719085 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91269886 |
| 54 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.90743000 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.90724377 |
| 56 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.86208651 |
| 57 | MYB_26560356_Chip-Seq_TH2_Human | 1.85713443 |
| 58 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.85376148 |
| 59 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.80685436 |
| 60 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.78603033 |
| 61 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.78297007 |
| 62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.75235439 |
| 63 | UTX_26944678_Chip-Seq_JUKART_Human | 1.72846707 |
| 64 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.70949921 |
| 65 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.70913385 |
| 66 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.70330542 |
| 67 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.67283806 |
| 68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.64970925 |
| 69 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.60447173 |
| 70 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.54442297 |
| 71 | P300_19829295_ChIP-Seq_ESCs_Human | 1.51727579 |
| 72 | MYB_26560356_Chip-Seq_TH1_Human | 1.51217671 |
| 73 | MAF_26560356_Chip-Seq_TH2_Human | 1.50923167 |
| 74 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.47816500 |
| 75 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.46455615 |
| 76 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.43889448 |
| 77 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.43164880 |
| 78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.42935604 |
| 79 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40096444 |
| 80 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.39809534 |
| 81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39063779 |
| 82 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.38674052 |
| 83 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.37430647 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37341446 |
| 85 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.36764125 |
| 86 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.36329807 |
| 87 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.36071872 |
| 88 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35439677 |
| 89 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35217432 |
| 90 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.34987054 |
| 91 | MYC_22102868_ChIP-Seq_BL_Human | 1.33757135 |
| 92 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.33079449 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32315653 |
| 94 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31584315 |
| 95 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.30152854 |
| 96 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.28940423 |
| 97 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.28558336 |
| 98 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28159771 |
| 99 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.27963574 |
| 100 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.27538785 |
| 101 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26486784 |
| 102 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.26184914 |
| 103 | VDR_22108803_ChIP-Seq_LS180_Human | 1.23510712 |
| 104 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.22776779 |
| 105 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.22605327 |
| 106 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22605176 |
| 107 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21542953 |
| 108 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21517851 |
| 109 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.21146982 |
| 110 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20158044 |
| 111 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.19464918 |
| 112 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19248111 |
| 113 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.18865542 |
| 114 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18071324 |
| 115 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.17563708 |
| 116 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16819597 |
| 117 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16348005 |
| 118 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.15544530 |
| 119 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14729402 |
| 120 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14389116 |
| 121 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12278979 |
| 122 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.12234775 |
| 123 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11740102 |
| 124 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.11682645 |
| 125 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11474096 |
| 126 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11206011 |
| 127 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.11178628 |
| 128 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10075174 |
| 129 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.09736593 |
| 130 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09674761 |
| 131 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.08670120 |
| 132 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08453761 |
| 133 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.07964120 |
| 134 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07827401 |
| 135 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.07415400 |
| 136 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07134248 |
| 137 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.07087964 |
| 138 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06011881 |
| 139 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.05866633 |
| 140 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05410918 |
| 141 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03534666 |
| 142 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03079087 |
| 143 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.02596840 |
| 144 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.01544910 |
| 145 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.00937783 |
| 146 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00898344 |
| 147 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00318066 |
| 148 | KDM2B_26808549_Chip-Seq_REH_Human | 1.00161108 |
| 149 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99931756 |
| 150 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.99386737 |
| 151 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.97983111 |
| 152 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97879157 |
| 153 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.95100304 |
| 154 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95011820 |
| 155 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.94891550 |
| 156 | AR_25329375_ChIP-Seq_VCAP_Human | 0.94864954 |
| 157 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94361669 |
| 158 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.93594414 |
| 159 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.93427775 |
| 160 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92877771 |
| 161 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92440035 |
| 162 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.92097918 |
| 163 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.91775603 |
| 164 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.91381480 |
| 165 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.90948798 |
| 166 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90032956 |
| 167 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.89700523 |
| 168 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.88636365 |
| 169 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88352410 |
| 170 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.87560578 |
| 171 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87433346 |
| 172 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.87363960 |
| 173 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.87079498 |
| 174 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.86803163 |
| 175 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.86294291 |
| 176 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85590985 |
| 177 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.85115480 |
| 178 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.84067095 |
| 179 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.83881731 |
| 180 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83842864 |
| 181 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83770845 |
| 182 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.83647027 |
| 183 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.82658924 |
| 184 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.82582400 |
| 185 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.82511798 |
| 186 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.82310294 |
| 187 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81974606 |
| 188 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.81277709 |
| 189 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.79584923 |
| 190 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.79553295 |
| 191 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.78984834 |
| 192 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.78003362 |
| 193 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.76689508 |
| 194 | GATA1_22025678_ChIP-Seq_K562_Human | 0.75910924 |
| 195 | P300_27268052_Chip-Seq_Bcells_Human | 0.75685226 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 5.99208279 |
| 2 | MP0005409_darkened_coat_color | 4.65876124 |
| 3 | MP0009379_abnormal_foot_pigmentation | 4.37038112 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.86062167 |
| 5 | MP0003436_decreased_susceptibility_to | 3.85333127 |
| 6 | MP0001188_hyperpigmentation | 3.69159721 |
| 7 | MP0003880_abnormal_central_pattern | 3.60983343 |
| 8 | MP0006082_CNS_inflammation | 3.23353615 |
| 9 | MP0001986_abnormal_taste_sensitivity | 3.22689387 |
| 10 | MP0005671_abnormal_response_to | 3.16870919 |
| 11 | MP0002419_abnormal_innate_immunity | 3.09278714 |
| 12 | MP0001790_abnormal_immune_system | 3.06283740 |
| 13 | MP0005387_immune_system_phenotype | 3.06283740 |
| 14 | MP0009785_altered_susceptibility_to | 3.01036012 |
| 15 | MP0000372_irregular_coat_pigmentation | 2.95494044 |
| 16 | MP0000685_abnormal_immune_system | 2.95303845 |
| 17 | MP0005025_abnormal_response_to | 2.90566662 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.90209202 |
| 19 | MP0001800_abnormal_humoral_immune | 2.89239155 |
| 20 | MP0008260_abnormal_autophagy | 2.84628440 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.80677354 |
| 22 | MP0002876_abnormal_thyroid_physiology | 2.78762943 |
| 23 | MP0005058_abnormal_lysosome_morphology | 2.68407952 |
| 24 | MP0002452_abnormal_antigen_presenting | 2.62652898 |
| 25 | MP0003172_abnormal_lysosome_physiology | 2.62424754 |
| 26 | MP0002723_abnormal_immune_serum | 2.61440973 |
| 27 | MP0006276_abnormal_autonomic_nervous | 2.58032216 |
| 28 | MP0001968_abnormal_touch/_nociception | 2.57809564 |
| 29 | MP0000015_abnormal_ear_pigmentation | 2.54865603 |
| 30 | MP0004381_abnormal_hair_follicle | 2.50607552 |
| 31 | MP0006292_abnormal_olfactory_placode | 2.49713678 |
| 32 | MP0002420_abnormal_adaptive_immunity | 2.40478820 |
| 33 | MP0001819_abnormal_immune_cell | 2.38831197 |
| 34 | MP0003724_increased_susceptibility_to | 2.33466430 |
| 35 | MP0003300_gastrointestinal_ulcer | 2.29458947 |
| 36 | MP0001533_abnormal_skeleton_physiology | 2.15692521 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 2.12209500 |
| 38 | MP0001970_abnormal_pain_threshold | 1.91415008 |
| 39 | MP0002405_respiratory_system_inflammati | 1.89970151 |
| 40 | MP0002736_abnormal_nociception_after | 1.89557528 |
| 41 | MP0004270_analgesia | 1.87505587 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.85602699 |
| 43 | MP0002638_abnormal_pupillary_reflex | 1.84938375 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.84166290 |
| 45 | MP0002734_abnormal_mechanical_nocicepti | 1.80854578 |
| 46 | MP0009764_decreased_sensitivity_to | 1.78490179 |
| 47 | MP0002272_abnormal_nervous_system | 1.76593031 |
| 48 | MP0009745_abnormal_behavioral_response | 1.74579232 |
| 49 | MP0000716_abnormal_immune_system | 1.73210651 |
| 50 | MP0002733_abnormal_thermal_nociception | 1.72582276 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.70863698 |
| 52 | MP0005174_abnormal_tail_pigmentation | 1.68337254 |
| 53 | MP0005171_absent_coat_pigmentation | 1.67348655 |
| 54 | MP0002751_abnormal_autonomic_nervous | 1.67199130 |
| 55 | MP0003183_abnormal_peptide_metabolism | 1.63507120 |
| 56 | MP0003763_abnormal_thymus_physiology | 1.63140640 |
| 57 | MP0010386_abnormal_urinary_bladder | 1.62652784 |
| 58 | MP0004510_myositis | 1.60894153 |
| 59 | MP0002064_seizures | 1.60515345 |
| 60 | MP0005310_abnormal_salivary_gland | 1.59281739 |
| 61 | MP0000604_amyloidosis | 1.58370995 |
| 62 | MP0003635_abnormal_synaptic_transmissio | 1.57631225 |
| 63 | MP0008469_abnormal_protein_level | 1.57418294 |
| 64 | MP0004947_skin_inflammation | 1.55446116 |
| 65 | MP0009333_abnormal_splenocyte_physiolog | 1.55301100 |
| 66 | MP0003075_altered_response_to | 1.55202632 |
| 67 | MP0002067_abnormal_sensory_capabilities | 1.54701068 |
| 68 | MP0002398_abnormal_bone_marrow | 1.54623229 |
| 69 | MP0001905_abnormal_dopamine_level | 1.53458999 |
| 70 | MP0009278_abnormal_bone_marrow | 1.53364431 |
| 71 | MP0009840_abnormal_foam_cell | 1.49772484 |
| 72 | MP0000343_altered_response_to | 1.48862425 |
| 73 | MP0003303_peritoneal_inflammation | 1.47354785 |
| 74 | MP0002557_abnormal_social/conspecific_i | 1.41474014 |
| 75 | MP0003690_abnormal_glial_cell | 1.39469088 |
| 76 | MP0002998_abnormal_bone_remodeling | 1.39255733 |
| 77 | MP0000689_abnormal_spleen_morphology | 1.35661188 |
| 78 | MP0004883_abnormal_blood_vessel | 1.32674350 |
| 79 | MP0000858_altered_metastatic_potential | 1.31186263 |
| 80 | MP0004742_abnormal_vestibular_system | 1.30579752 |
| 81 | MP0002429_abnormal_blood_cell | 1.29372652 |
| 82 | MP0005084_abnormal_gallbladder_morpholo | 1.27188996 |
| 83 | MP0003866_abnormal_defecation | 1.26852744 |
| 84 | MP0002184_abnormal_innervation | 1.25992702 |
| 85 | MP0002572_abnormal_emotion/affect_behav | 1.25617996 |
| 86 | MP0000465_gastrointestinal_hemorrhage | 1.25224696 |
| 87 | MP0009046_muscle_twitch | 1.23970584 |
| 88 | MP0002722_abnormal_immune_system | 1.23964112 |
| 89 | MP0004272_abnormal_basement_membrane | 1.21669389 |
| 90 | MP0001486_abnormal_startle_reflex | 1.21471574 |
| 91 | MP0005165_increased_susceptibility_to | 1.20846794 |
| 92 | MP0003868_abnormal_feces_composition | 1.19443571 |
| 93 | MP0005257_abnormal_intraocular_pressure | 1.18000629 |
| 94 | MP0003879_abnormal_hair_cell | 1.16669574 |
| 95 | MP0004859_abnormal_synaptic_plasticity | 1.13912169 |
| 96 | MP0001529_abnormal_vocalization | 1.10589219 |
| 97 | MP0005451_abnormal_body_composition | 1.10505345 |
| 98 | MP0004142_abnormal_muscle_tone | 1.10416058 |
| 99 | MP0002177_abnormal_outer_ear | 1.10278974 |
| 100 | MP0001440_abnormal_grooming_behavior | 1.09444855 |
| 101 | MP0003806_abnormal_nucleotide_metabolis | 1.09444477 |
| 102 | MP0005166_decreased_susceptibility_to | 1.08491508 |
| 103 | MP0005397_hematopoietic_system_phenotyp | 1.07817660 |
| 104 | MP0001545_abnormal_hematopoietic_system | 1.07817660 |
| 105 | MP0008569_lethality_at_weaning | 1.07693055 |
| 106 | MP0005423_abnormal_somatic_nervous | 1.06520581 |
| 107 | MP0001853_heart_inflammation | 1.06514905 |
| 108 | MP0005408_hypopigmentation | 1.05853410 |
| 109 | MP0002938_white_spotting | 1.03916528 |
| 110 | MP0005379_endocrine/exocrine_gland_phen | 1.03512629 |
| 111 | MP0000569_abnormal_digit_pigmentation | 1.03480563 |
| 112 | MP0005164_abnormal_response_to | 1.02400066 |
| 113 | MP0005390_skeleton_phenotype | 0.99883293 |
| 114 | MP0003448_altered_tumor_morphology | 0.99804329 |
| 115 | MP0000778_abnormal_nervous_system | 0.99439033 |
| 116 | MP0002229_neurodegeneration | 0.99403848 |
| 117 | MP0002132_abnormal_respiratory_system | 0.98151525 |
| 118 | MP0003938_abnormal_ear_development | 0.97820938 |
| 119 | MP0000026_abnormal_inner_ear | 0.97533790 |
| 120 | MP0000681_abnormal_thyroid_gland | 0.97330178 |
| 121 | MP0001963_abnormal_hearing_physiology | 0.96299110 |
| 122 | MP0002138_abnormal_hepatobiliary_system | 0.95611142 |
| 123 | MP0001664_abnormal_digestion | 0.92444724 |
| 124 | MP0001851_eye_inflammation | 0.91448626 |
| 125 | MP0003329_amyloid_beta_deposits | 0.90466803 |
| 126 | MP0005595_abnormal_vascular_smooth | 0.88863162 |
| 127 | MP0000703_abnormal_thymus_morphology | 0.88616682 |
| 128 | MP0000566_synostosis | 0.88422128 |
| 129 | MP0000920_abnormal_myelination | 0.87124067 |
| 130 | MP0003279_aneurysm | 0.85788225 |
| 131 | MP0009763_increased_sensitivity_to | 0.85594248 |
| 132 | MP0001501_abnormal_sleep_pattern | 0.85408515 |
| 133 | MP0002095_abnormal_skin_pigmentation | 0.84451138 |
| 134 | MP0000631_abnormal_neuroendocrine_gland | 0.84400238 |
| 135 | MP0001958_emphysema | 0.83261973 |
| 136 | MP0002882_abnormal_neuron_morphology | 0.83149923 |
| 137 | MP0002933_joint_inflammation | 0.82792192 |
| 138 | MP0002752_abnormal_somatic_nervous | 0.82140052 |
| 139 | MP0008789_abnormal_olfactory_epithelium | 0.81886914 |
| 140 | MP0005167_abnormal_blood-brain_barrier | 0.80104124 |
| 141 | MP0002148_abnormal_hypersensitivity_rea | 0.79646995 |
| 142 | MP0002063_abnormal_learning/memory/cond | 0.79523331 |
| 143 | MP0000613_abnormal_salivary_gland | 0.79295011 |
| 144 | MP0005551_abnormal_eye_electrophysiolog | 0.79245630 |
| 145 | MP0003315_abnormal_perineum_morphology | 0.78852744 |
| 146 | MP0001873_stomach_inflammation | 0.77058837 |
| 147 | MP0000371_diluted_coat_color | 0.74942935 |
| 148 | MP0001663_abnormal_digestive_system | 0.73494112 |
| 149 | MP0002160_abnormal_reproductive_system | 0.73066583 |
| 150 | MP0003795_abnormal_bone_structure | 0.72821320 |
| 151 | MP0002066_abnormal_motor_capabilities/c | 0.72294752 |
| 152 | MP0003011_delayed_dark_adaptation | 0.70349938 |
| 153 | MP0001661_extended_life_span | 0.70329892 |
| 154 | MP0005075_abnormal_melanosome_morpholog | 0.70272196 |
| 155 | MP0006054_spinal_hemorrhage | 0.69166018 |
| 156 | MP0003959_abnormal_lean_body | 0.68786941 |
| 157 | MP0000249_abnormal_blood_vessel | 0.68083265 |
| 158 | MP0000955_abnormal_spinal_cord | 0.67028901 |
| 159 | MP0008004_abnormal_stomach_pH | 0.66747793 |
| 160 | MP0005394_taste/olfaction_phenotype | 0.66541904 |
| 161 | MP0005499_abnormal_olfactory_system | 0.66541904 |
| 162 | MP0003045_fibrosis | 0.65196302 |
| 163 | MP0001542_abnormal_bone_strength | 0.64666569 |
| 164 | MP0003634_abnormal_glial_cell | 0.64643240 |
| 165 | MP0002254_reproductive_system_inflammat | 0.64450225 |
| 166 | MP0008874_decreased_physiological_sensi | 0.63503777 |
| 167 | MP0002277_abnormal_respiratory_mucosa | 0.62454599 |
| 168 | MP0003091_abnormal_cell_migration | 0.62283656 |
| 169 | MP0009765_abnormal_xenobiotic_induced | 0.61606126 |
| 170 | MP0005381_digestive/alimentary_phenotyp | 0.61017244 |
| 171 | MP0002332_abnormal_exercise_endurance | 0.60202106 |
| 172 | MP0002102_abnormal_ear_morphology | 0.60149095 |
| 173 | MP0002166_altered_tumor_susceptibility | 0.59398905 |
| 174 | MP0001984_abnormal_olfaction | 0.58067007 |
| 175 | MP0003828_pulmonary_edema | 0.57899921 |
| 176 | MP0000230_abnormal_systemic_arterial | 0.57830460 |
| 177 | MP0000049_abnormal_middle_ear | 0.57702901 |
| 178 | MP0005410_abnormal_fertilization | 0.55888645 |
| 179 | MP0001502_abnormal_circadian_rhythm | 0.55779879 |
| 180 | MP0004145_abnormal_muscle_electrophysio | 0.54837311 |
| 181 | MP0002693_abnormal_pancreas_physiology | 0.53537765 |
| 182 | MP0005319_abnormal_enzyme/_coenzyme | 0.52785366 |
| 183 | MP0003453_abnormal_keratinocyte_physiol | 0.50573354 |
| 184 | MP0002653_abnormal_ependyma_morphology | 0.46755232 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.86968506 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.65397673 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.46110744 |
| 4 | Agitation (HP:0000713) | 5.44744610 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.44706621 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 5.20683586 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.20683586 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.20683586 |
| 9 | Myositis (HP:0100614) | 4.90405169 |
| 10 | Type I transferrin isoform profile (HP:0003642) | 4.87551103 |
| 11 | Orchitis (HP:0100796) | 4.66270433 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 4.44902062 |
| 13 | Optic neuritis (HP:0100653) | 4.44902062 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.40032268 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 4.35031523 |
| 16 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 4.24683213 |
| 17 | Hypothermia (HP:0002045) | 4.05151681 |
| 18 | Reduced antithrombin III activity (HP:0001976) | 4.00884820 |
| 19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.98931284 |
| 20 | Restlessness (HP:0000711) | 3.97302480 |
| 21 | Recurrent fungal infections (HP:0002841) | 3.94848364 |
| 22 | Increased hepatocellular lipid droplets (HP:0006565) | 3.83709881 |
| 23 | Ulnar claw (HP:0001178) | 3.81972334 |
| 24 | Recurrent skin infections (HP:0001581) | 3.80836897 |
| 25 | Hypercortisolism (HP:0001578) | 3.76131600 |
| 26 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.73158951 |
| 27 | Renal Fanconi syndrome (HP:0001994) | 3.72794153 |
| 28 | Increased cerebral lipofuscin (HP:0011813) | 3.71243612 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.58247226 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 3.58247226 |
| 31 | Focal motor seizures (HP:0011153) | 3.56984635 |
| 32 | Sensory axonal neuropathy (HP:0003390) | 3.55972522 |
| 33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.53596707 |
| 34 | Meningitis (HP:0001287) | 3.53498982 |
| 35 | Gastrointestinal infarctions (HP:0005244) | 3.50401916 |
| 36 | Acute necrotizing encephalopathy (HP:0006965) | 3.45215113 |
| 37 | Optic disc pallor (HP:0000543) | 3.41422355 |
| 38 | 3-Methylglutaconic aciduria (HP:0003535) | 3.41203493 |
| 39 | Mitochondrial inheritance (HP:0001427) | 3.39863576 |
| 40 | Dysostosis multiplex (HP:0000943) | 3.35291478 |
| 41 | Vasculitis (HP:0002633) | 3.32403936 |
| 42 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.30672227 |
| 43 | Hypoplasia of the fovea (HP:0007750) | 3.30672227 |
| 44 | Nonprogressive disorder (HP:0003680) | 3.28861780 |
| 45 | Lipid accumulation in hepatocytes (HP:0006561) | 3.24589127 |
| 46 | Pulmonary infiltrates (HP:0002113) | 3.21501748 |
| 47 | Systemic lupus erythematosus (HP:0002725) | 3.16555423 |
| 48 | Increased IgE level (HP:0003212) | 3.14443409 |
| 49 | Myokymia (HP:0002411) | 3.14209396 |
| 50 | Loss of speech (HP:0002371) | 3.13865159 |
| 51 | Abnormality of magnesium homeostasis (HP:0004921) | 3.13231954 |
| 52 | Spontaneous hematomas (HP:0007420) | 3.12441001 |
| 53 | Abnormality of secondary sexual hair (HP:0009888) | 3.11300899 |
| 54 | Abnormality of the axillary hair (HP:0100134) | 3.11300899 |
| 55 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.06950952 |
| 56 | Encephalitis (HP:0002383) | 3.04760018 |
| 57 | Keratoconjunctivitis sicca (HP:0001097) | 3.04286965 |
| 58 | Gingivitis (HP:0000230) | 3.04012055 |
| 59 | Hemoptysis (HP:0002105) | 3.03992991 |
| 60 | Urticaria (HP:0001025) | 3.03318209 |
| 61 | Attenuation of retinal blood vessels (HP:0007843) | 3.02546717 |
| 62 | Abnormal protein glycosylation (HP:0012346) | 3.00141563 |
| 63 | Abnormal glycosylation (HP:0012345) | 3.00141563 |
| 64 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.00141563 |
| 65 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.00141563 |
| 66 | Hepatocellular necrosis (HP:0001404) | 2.89025274 |
| 67 | Pustule (HP:0200039) | 2.88175471 |
| 68 | Keratoconjunctivitis (HP:0001096) | 2.86081686 |
| 69 | Progressive macrocephaly (HP:0004481) | 2.85379750 |
| 70 | Dry hair (HP:0011359) | 2.82858467 |
| 71 | Hypomagnesemia (HP:0002917) | 2.82363693 |
| 72 | Lower limb hyperreflexia (HP:0002395) | 2.76714185 |
| 73 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.76673834 |
| 74 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.71983620 |
| 75 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.71983620 |
| 76 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.71983620 |
| 77 | Recurrent viral infections (HP:0004429) | 2.71925127 |
| 78 | Cellulitis (HP:0100658) | 2.71487146 |
| 79 | Abnormality of the fovea (HP:0000493) | 2.63849702 |
| 80 | Exertional dyspnea (HP:0002875) | 2.62033443 |
| 81 | Disinhibition (HP:0000734) | 2.60548154 |
| 82 | Testicular atrophy (HP:0000029) | 2.57819457 |
| 83 | Autoimmune thrombocytopenia (HP:0001973) | 2.57590533 |
| 84 | Amyloidosis (HP:0011034) | 2.57048883 |
| 85 | T lymphocytopenia (HP:0005403) | 2.56620177 |
| 86 | Acute encephalopathy (HP:0006846) | 2.56017788 |
| 87 | Increased IgM level (HP:0003496) | 2.54640949 |
| 88 | Abnormality of T cell number (HP:0011839) | 2.53744192 |
| 89 | Abnormality of renal resorption (HP:0011038) | 2.50854909 |
| 90 | Abnormal sex determination (HP:0012244) | 2.50339221 |
| 91 | Sex reversal (HP:0012245) | 2.50339221 |
| 92 | Increased CSF lactate (HP:0002490) | 2.49271138 |
| 93 | Chest pain (HP:0100749) | 2.47686899 |
| 94 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.45005636 |
| 95 | Mucopolysacchariduria (HP:0008155) | 2.45005636 |
| 96 | Mutism (HP:0002300) | 2.44644605 |
| 97 | Leukocytosis (HP:0001974) | 2.44521314 |
| 98 | Purpura (HP:0000979) | 2.42505081 |
| 99 | Vacuolated lymphocytes (HP:0001922) | 2.39257681 |
| 100 | Inflammation of the large intestine (HP:0002037) | 2.39121314 |
| 101 | Episodic fever (HP:0001954) | 2.38612442 |
| 102 | Gastrointestinal stroma tumor (HP:0100723) | 2.38475320 |
| 103 | Adrenal overactivity (HP:0002717) | 2.36784613 |
| 104 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.35308525 |
| 105 | Microvesicular hepatic steatosis (HP:0001414) | 2.34323110 |
| 106 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.34309802 |
| 107 | Absent/shortened dynein arms (HP:0200106) | 2.34309802 |
| 108 | Peritonitis (HP:0002586) | 2.34207781 |
| 109 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.34132219 |
| 110 | Panhypogammaglobulinemia (HP:0003139) | 2.32817216 |
| 111 | Abnormal ciliary motility (HP:0012262) | 2.32244017 |
| 112 | Striae distensae (HP:0001065) | 2.32112871 |
| 113 | Hepatic necrosis (HP:0002605) | 2.31998035 |
| 114 | Glomerulonephritis (HP:0000099) | 2.31746248 |
| 115 | Abnormality of T cells (HP:0002843) | 2.30285873 |
| 116 | Prolonged bleeding time (HP:0003010) | 2.29342233 |
| 117 | Hypergammaglobulinemia (HP:0010702) | 2.28850104 |
| 118 | Petechiae (HP:0000967) | 2.28735647 |
| 119 | Gastrointestinal inflammation (HP:0004386) | 2.26127878 |
| 120 | Parakeratosis (HP:0001036) | 2.25253909 |
| 121 | Steppage gait (HP:0003376) | 2.24246258 |
| 122 | Pulmonary embolism (HP:0002204) | 2.24204137 |
| 123 | Thyroid-stimulating hormone excess (HP:0002925) | 2.24128604 |
| 124 | Increased intramyocellular lipid droplets (HP:0012240) | 2.23153000 |
| 125 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.22320132 |
| 126 | Hypochromic anemia (HP:0001931) | 2.21511641 |
| 127 | Lymphopenia (HP:0001888) | 2.21022305 |
| 128 | Gingival bleeding (HP:0000225) | 2.20623597 |
| 129 | Abnormality of the pleura (HP:0002103) | 2.20268625 |
| 130 | Osteomyelitis (HP:0002754) | 2.19566992 |
| 131 | Short tibia (HP:0005736) | 2.19544741 |
| 132 | Agammaglobulinemia (HP:0004432) | 2.19339158 |
| 133 | Recurrent bronchitis (HP:0002837) | 2.18703277 |
| 134 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.18456928 |
| 135 | Increased serum ferritin (HP:0003281) | 2.17658162 |
| 136 | Anorexia (HP:0002039) | 2.17334499 |
| 137 | Recurrent pneumonia (HP:0006532) | 2.16287292 |
| 138 | Abnormality of the peritoneum (HP:0002585) | 2.15549729 |
| 139 | Peripheral hypomyelination (HP:0007182) | 2.15039067 |
| 140 | Restrictive lung disease (HP:0002091) | 2.14984267 |
| 141 | Anxiety (HP:0000739) | 2.14592277 |
| 142 | Colitis (HP:0002583) | 2.13671025 |
| 143 | Epistaxis (HP:0000421) | 2.13601199 |
| 144 | Arterial thrombosis (HP:0004420) | 2.13393114 |
| 145 | Hematochezia (HP:0002573) | 2.12411320 |
| 146 | Basal ganglia calcification (HP:0002135) | 2.11826610 |
| 147 | Gangrene (HP:0100758) | 2.11410638 |
| 148 | Hypochromic microcytic anemia (HP:0004840) | 2.10708237 |
| 149 | Cerebral edema (HP:0002181) | 2.10664956 |
| 150 | Progressive external ophthalmoplegia (HP:0000590) | 2.08415908 |
| 151 | Cortical visual impairment (HP:0100704) | 2.07059141 |
| 152 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.07033847 |
| 153 | Hepatosplenomegaly (HP:0001433) | 2.07022508 |
| 154 | Recurrent sinusitis (HP:0011108) | 2.04009413 |
| 155 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.03341009 |
| 156 | IgM deficiency (HP:0002850) | 2.03320043 |
| 157 | Gaze-evoked nystagmus (HP:0000640) | 2.03014569 |
| 158 | Atonic seizures (HP:0010819) | 2.02814465 |
| 159 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.02395071 |
| 160 | Abnormality of T cell physiology (HP:0011840) | 2.01876203 |
| 161 | Progressive inability to walk (HP:0002505) | 2.01028314 |
| 162 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.98786314 |
| 163 | Recurrent lower respiratory tract infections (HP:0002783) | 1.98034032 |
| 164 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.97950559 |
| 165 | Sepsis (HP:0100806) | 1.97727839 |
| 166 | Renal tubular dysfunction (HP:0000124) | 1.96707534 |
| 167 | Progressive neurologic deterioration (HP:0002344) | 1.96170821 |
| 168 | Medial flaring of the eyebrow (HP:0010747) | 1.94537545 |
| 169 | Abnormality of iron homeostasis (HP:0011031) | 1.94022749 |
| 170 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.93122551 |
| 171 | Acne (HP:0001061) | 1.92576094 |
| 172 | Febrile seizures (HP:0002373) | 1.92421754 |
| 173 | Granulocytopenia (HP:0001913) | 1.92107305 |
| 174 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.91556911 |
| 175 | Hyperphosphaturia (HP:0003109) | 1.91138583 |
| 176 | Stomatitis (HP:0010280) | 1.89684835 |
| 177 | Congenital glaucoma (HP:0001087) | 1.87099559 |
| 178 | Impaired proprioception (HP:0010831) | 1.84857529 |
| 179 | Exercise intolerance (HP:0003546) | 1.84283453 |
| 180 | Focal seizures (HP:0007359) | 1.83858934 |
| 181 | Stage 5 chronic kidney disease (HP:0003774) | 1.83780200 |
| 182 | Chronic obstructive pulmonary disease (HP:0006510) | 1.83264593 |
| 183 | Obstructive lung disease (HP:0006536) | 1.83264593 |
| 184 | Blue irides (HP:0000635) | 1.80097073 |
| 185 | Psychosis (HP:0000709) | 1.79531484 |
| 186 | Late onset (HP:0003584) | 1.77653067 |
| 187 | Depression (HP:0000716) | 1.77022108 |
| 188 | Capillary hemangiomas (HP:0005306) | 1.76956005 |
| 189 | Abnormal urine phosphate concentration (HP:0012599) | 1.76918885 |
| 190 | Gait imbalance (HP:0002141) | 1.75208346 |
| 191 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.74522753 |
| 192 | Patchy hypopigmentation of hair (HP:0011365) | 1.73893533 |
| 193 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.73674731 |
| 194 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.73674731 |
| 195 | Limb dystonia (HP:0002451) | 1.71906691 |
| 196 | Increased muscle lipid content (HP:0009058) | 1.71646554 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 5.24319374 |
| 2 | CASK | 4.47927268 |
| 3 | MAPK13 | 4.13135991 |
| 4 | TNIK | 4.03937264 |
| 5 | MAP4K1 | 3.60546617 |
| 6 | TYK2 | 3.10457875 |
| 7 | ERN1 | 2.77297372 |
| 8 | FES | 2.63629728 |
| 9 | MKNK2 | 2.47910516 |
| 10 | MUSK | 2.45927311 |
| 11 | TBK1 | 2.03342820 |
| 12 | IRAK3 | 2.02783752 |
| 13 | MAP2K3 | 2.02479587 |
| 14 | JAK3 | 2.01171789 |
| 15 | IKBKE | 1.96498562 |
| 16 | MAPK12 | 1.95850182 |
| 17 | GRK5 | 1.95756520 |
| 18 | MAP3K13 | 1.93590428 |
| 19 | MAP3K11 | 1.90559946 |
| 20 | TEC | 1.87950255 |
| 21 | ZAP70 | 1.86961685 |
| 22 | TXK | 1.82375657 |
| 23 | TLK1 | 1.78290939 |
| 24 | MAP3K12 | 1.75695816 |
| 25 | MST4 | 1.67993651 |
| 26 | GRK6 | 1.67402094 |
| 27 | TAOK3 | 1.63885719 |
| 28 | STK16 | 1.61698511 |
| 29 | RIPK4 | 1.58107826 |
| 30 | MAP3K3 | 1.57637879 |
| 31 | PIM2 | 1.53334937 |
| 32 | CSF1R | 1.52979156 |
| 33 | EPHB1 | 1.52318242 |
| 34 | STK39 | 1.50094582 |
| 35 | GRK7 | 1.49291104 |
| 36 | TAOK1 | 1.48381092 |
| 37 | JAK1 | 1.47279580 |
| 38 | HCK | 1.46539499 |
| 39 | PRPF4B | 1.41182058 |
| 40 | IRAK4 | 1.40658652 |
| 41 | IKBKB | 1.39387024 |
| 42 | ARAF | 1.39381812 |
| 43 | MAPK11 | 1.38914605 |
| 44 | TESK2 | 1.36472807 |
| 45 | MAP2K7 | 1.35945624 |
| 46 | SIK3 | 1.28760769 |
| 47 | IRAK2 | 1.27035284 |
| 48 | CAMK1 | 1.26097662 |
| 49 | TGFBR2 | 1.25059826 |
| 50 | ADRBK2 | 1.22259464 |
| 51 | PRKD2 | 1.20948441 |
| 52 | LCK | 1.20729031 |
| 53 | AKT3 | 1.16990316 |
| 54 | MKNK1 | 1.16642851 |
| 55 | FER | 1.15845165 |
| 56 | NTRK3 | 1.14457630 |
| 57 | JAK2 | 1.11697526 |
| 58 | CDC42BPA | 1.07594620 |
| 59 | MAPK15 | 1.06368376 |
| 60 | NME1 | 1.06323806 |
| 61 | ITK | 1.03321765 |
| 62 | BMPR1B | 1.02835202 |
| 63 | BLK | 1.01395939 |
| 64 | FGR | 1.00553113 |
| 65 | NLK | 0.99690563 |
| 66 | UHMK1 | 0.96205473 |
| 67 | CAMKK2 | 0.95597041 |
| 68 | IRAK1 | 0.95281196 |
| 69 | CAMK2B | 0.94555052 |
| 70 | EIF2AK3 | 0.93957842 |
| 71 | MARK2 | 0.91534441 |
| 72 | OXSR1 | 0.89610464 |
| 73 | YES1 | 0.87957385 |
| 74 | MARK3 | 0.86133099 |
| 75 | INSRR | 0.85795185 |
| 76 | MAPKAPK5 | 0.85243636 |
| 77 | BMPR2 | 0.80874645 |
| 78 | KSR2 | 0.78412206 |
| 79 | MAPK7 | 0.77943996 |
| 80 | BRAF | 0.77504915 |
| 81 | MYLK | 0.76749860 |
| 82 | CDK19 | 0.75902526 |
| 83 | SRPK1 | 0.75124886 |
| 84 | WNK4 | 0.74549885 |
| 85 | CSNK1G3 | 0.74516955 |
| 86 | PDK1 | 0.74515063 |
| 87 | TAOK2 | 0.74485667 |
| 88 | CDK14 | 0.73027717 |
| 89 | MAPK4 | 0.72197262 |
| 90 | CLK1 | 0.72171359 |
| 91 | CSNK1G1 | 0.71907085 |
| 92 | MOS | 0.70255877 |
| 93 | PDPK1 | 0.69643863 |
| 94 | HIPK2 | 0.68210932 |
| 95 | EPHA3 | 0.67707726 |
| 96 | MAP3K6 | 0.65685919 |
| 97 | GRK1 | 0.65192383 |
| 98 | FYN | 0.63539604 |
| 99 | LIMK1 | 0.62804762 |
| 100 | PTK2B | 0.62202444 |
| 101 | PRKCQ | 0.60917636 |
| 102 | DYRK1B | 0.58486743 |
| 103 | CAMK2A | 0.58094188 |
| 104 | EPHB2 | 0.56635217 |
| 105 | PRKCE | 0.56409529 |
| 106 | FGFR4 | 0.56371767 |
| 107 | TRIB3 | 0.56274033 |
| 108 | EIF2AK2 | 0.55221100 |
| 109 | PRKACA | 0.54999503 |
| 110 | MARK1 | 0.52913578 |
| 111 | ADRBK1 | 0.52652411 |
| 112 | NTRK1 | 0.52629618 |
| 113 | CHUK | 0.52595880 |
| 114 | DYRK2 | 0.51463834 |
| 115 | CSK | 0.50996004 |
| 116 | CAMK2D | 0.50867079 |
| 117 | MAP2K2 | 0.50587150 |
| 118 | STK10 | 0.49550513 |
| 119 | PIK3CG | 0.49331847 |
| 120 | TNK2 | 0.47005803 |
| 121 | RPS6KL1 | 0.46849100 |
| 122 | RPS6KC1 | 0.46849100 |
| 123 | DAPK2 | 0.46290751 |
| 124 | PTK6 | 0.45300394 |
| 125 | RPS6KA6 | 0.45260519 |
| 126 | CSNK1A1L | 0.45197290 |
| 127 | BTK | 0.44073685 |
| 128 | CSNK1G2 | 0.43670541 |
| 129 | LYN | 0.43390049 |
| 130 | TIE1 | 0.42632817 |
| 131 | MAP3K7 | 0.42331660 |
| 132 | PKN1 | 0.41661007 |
| 133 | ABL1 | 0.41595305 |
| 134 | MAP3K5 | 0.41317522 |
| 135 | VRK1 | 0.41093446 |
| 136 | PRKG1 | 0.40286768 |
| 137 | PNCK | 0.40049184 |
| 138 | CAMKK1 | 0.39562414 |
| 139 | SIK1 | 0.39144204 |
| 140 | RPS6KA2 | 0.38468483 |
| 141 | MAP2K6 | 0.38099391 |
| 142 | PRKCD | 0.37594800 |
| 143 | MAP2K4 | 0.37426818 |
| 144 | DDR2 | 0.36632427 |
| 145 | CDK5 | 0.36489186 |
| 146 | MATK | 0.36072120 |
| 147 | CAMK2G | 0.36059165 |
| 148 | PRKCZ | 0.35463033 |
| 149 | FGFR3 | 0.35279683 |
| 150 | PRKD1 | 0.34971861 |
| 151 | KIT | 0.34803285 |
| 152 | SGK223 | 0.34055857 |
| 153 | SGK494 | 0.34055857 |
| 154 | SYK | 0.33940749 |
| 155 | MINK1 | 0.33688378 |
| 156 | MAP3K14 | 0.33671365 |
| 157 | MAP3K1 | 0.33645113 |
| 158 | NEK6 | 0.33270531 |
| 159 | PRKG2 | 0.32944994 |
| 160 | SIK2 | 0.32934963 |
| 161 | EPHA4 | 0.32647806 |
| 162 | LRRK2 | 0.32643628 |
| 163 | MAPKAPK2 | 0.32201366 |
| 164 | PIM1 | 0.30517954 |
| 165 | DYRK1A | 0.30379129 |
| 166 | PRKCH | 0.30060181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.39148351 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.21935291 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.19546452 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.84860846 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.77449251 |
| 6 | Alzheimers disease_Homo sapiens_hsa05010 | 2.76857036 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 2.69715085 |
| 8 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.64556746 |
| 9 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.63842139 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.61650469 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.45251991 |
| 12 | Phototransduction_Homo sapiens_hsa04744 | 2.27286691 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 2.25607459 |
| 14 | Huntingtons disease_Homo sapiens_hsa05016 | 2.25127410 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.20281876 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.17683470 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.15080632 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.11790664 |
| 19 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.11759001 |
| 20 | Nicotine addiction_Homo sapiens_hsa05033 | 2.10934964 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.00090118 |
| 22 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.97621984 |
| 23 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.96657795 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.89686683 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.89216057 |
| 26 | Morphine addiction_Homo sapiens_hsa05032 | 1.82891965 |
| 27 | Taste transduction_Homo sapiens_hsa04742 | 1.76028679 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.74224966 |
| 29 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.71667808 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.71496032 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.70950484 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.69190420 |
| 33 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.66596718 |
| 34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.64038152 |
| 35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.56028963 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.55823746 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54656473 |
| 38 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.54408215 |
| 39 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.52466295 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.51797353 |
| 41 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.50273869 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 1.49446095 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.45075480 |
| 44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.43049986 |
| 45 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.42504459 |
| 46 | Measles_Homo sapiens_hsa05162 | 1.41144251 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.40046602 |
| 48 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.39433885 |
| 49 | GABAergic synapse_Homo sapiens_hsa04727 | 1.30396358 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.29785361 |
| 51 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.26240953 |
| 52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.26117023 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.26000119 |
| 54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.25993774 |
| 55 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.25986339 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.25366701 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 1.24740267 |
| 58 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.24408526 |
| 59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.21511110 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.19028685 |
| 61 | RNA polymerase_Homo sapiens_hsa03020 | 1.16086156 |
| 62 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.12790425 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 1.12570365 |
| 64 | Long-term depression_Homo sapiens_hsa04730 | 1.05319117 |
| 65 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05128375 |
| 66 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04903434 |
| 67 | Salivary secretion_Homo sapiens_hsa04970 | 1.03820099 |
| 68 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.03613567 |
| 69 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.02839786 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.00455812 |
| 71 | Circadian entrainment_Homo sapiens_hsa04713 | 0.99745951 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.99083878 |
| 73 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.98643296 |
| 74 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.98001892 |
| 75 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.97406193 |
| 76 | Insulin secretion_Homo sapiens_hsa04911 | 0.96247562 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.95857038 |
| 78 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.93167247 |
| 79 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.91453994 |
| 80 | Hepatitis B_Homo sapiens_hsa05161 | 0.90516237 |
| 81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.90383835 |
| 82 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.89720842 |
| 83 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.89691894 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.89291819 |
| 85 | Shigellosis_Homo sapiens_hsa05131 | 0.84190326 |
| 86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83780246 |
| 87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82529676 |
| 88 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.81150298 |
| 89 | Apoptosis_Homo sapiens_hsa04210 | 0.79107431 |
| 90 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.78890699 |
| 91 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.77082889 |
| 92 | Platelet activation_Homo sapiens_hsa04611 | 0.77026125 |
| 93 | Purine metabolism_Homo sapiens_hsa00230 | 0.75476711 |
| 94 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.74348100 |
| 95 | Cocaine addiction_Homo sapiens_hsa05030 | 0.73161901 |
| 96 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.68502665 |
| 97 | Axon guidance_Homo sapiens_hsa04360 | 0.68396981 |
| 98 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.67804130 |
| 99 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.67693314 |
| 100 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.67512721 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.66645183 |
| 102 | Proteasome_Homo sapiens_hsa03050 | 0.66072168 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65614915 |
| 104 | Pertussis_Homo sapiens_hsa05133 | 0.63881031 |
| 105 | Malaria_Homo sapiens_hsa05144 | 0.63823003 |
| 106 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62651898 |
| 107 | Olfactory transduction_Homo sapiens_hsa04740 | 0.61647132 |
| 108 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61020923 |
| 109 | Renin secretion_Homo sapiens_hsa04924 | 0.59951321 |
| 110 | Histidine metabolism_Homo sapiens_hsa00340 | 0.59270631 |
| 111 | Melanogenesis_Homo sapiens_hsa04916 | 0.58606996 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57769718 |
| 113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57293350 |
| 114 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57132104 |
| 115 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56352083 |
| 116 | Long-term potentiation_Homo sapiens_hsa04720 | 0.55506754 |
| 117 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.54890606 |
| 118 | Asthma_Homo sapiens_hsa05310 | 0.54254637 |
| 119 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.54003900 |
| 120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52955910 |
| 121 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.52587438 |
| 122 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52548250 |
| 123 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.52355775 |
| 124 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52290347 |
| 125 | Mineral absorption_Homo sapiens_hsa04978 | 0.50629643 |
| 126 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50138752 |
| 127 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49872891 |
| 128 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49794684 |
| 129 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49451760 |
| 130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49377471 |
| 131 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.49018854 |
| 132 | Amoebiasis_Homo sapiens_hsa05146 | 0.47506249 |
| 133 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46795467 |
| 134 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.45579634 |
| 135 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.45220457 |
| 136 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.43149714 |
| 137 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.42993347 |
| 138 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.42876392 |
| 139 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41526912 |
| 140 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41461514 |
| 141 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40936689 |
| 142 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40017051 |
| 143 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.38918161 |
| 144 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.38703267 |
| 145 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.38559596 |
| 146 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.38065786 |
| 147 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37884165 |
| 148 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37812009 |
| 149 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37384060 |
| 150 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36169613 |
| 151 | Allograft rejection_Homo sapiens_hsa05330 | 0.35376519 |
| 152 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.35203621 |
| 153 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.33276676 |
| 154 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.33052602 |
| 155 | Homologous recombination_Homo sapiens_hsa03440 | 0.31748911 |
| 156 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31464694 |
| 157 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31086835 |
| 158 | Gap junction_Homo sapiens_hsa04540 | 0.30938228 |
| 159 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.30916499 |
| 160 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30643899 |
| 161 | Lysosome_Homo sapiens_hsa04142 | 0.30533616 |
| 162 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.29634649 |
| 163 | Prion diseases_Homo sapiens_hsa05020 | 0.29179384 |
| 164 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.28610654 |
| 165 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27190109 |
| 166 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26955784 |
| 167 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24648182 |
| 168 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24315436 |
| 169 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.23875245 |
| 170 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.23829566 |
| 171 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.22662240 |
| 172 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.21420885 |

